載入...
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
Lung cancer patients are at heightened risk for developing COVID-19 infection as well as complications due to multiple risk factors such as underlying malignancy, anti-cancer treatment induced immunosuppression, additional comorbidities and history of smoking. Recent literatures have reported a sign...
Na minha lista:
| 發表在: | Arch Med Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
IMSS. Published by Elsevier Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670900/ https://ncbi.nlm.nih.gov/pubmed/33257051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arcmed.2020.11.006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|